AOCNP EXAM STUDY GUIDE – 120+ REVIEW QUESTIONS & TERMS
FOR ADVANCED ONCOLOGY CERTIFIED NURSE PRACTITIONER
(2026) BOARD EXAM PREP (PDF)
AOCNP® 2026 Board Exam Preparation
Comprehensive Academic Practice Examination
120+ Review Questions, Clinical Scenarios, and Key Concepts
Institution: __________________________________________
Examination Type: Advanced Oncology Certified Nurse Practitioner (AOCNP®)
Practice Examination
Recommended Level: Graduate/Advanced Practice Nursing
Total Questions: 125
Format: Multiple Choice and Short Answer
Purpose: Board-examination preparation and advanced oncology knowledge
assessment
Important educational notice: This is an original practice examination created for
study and educational use.
Table of Contents
1. Section I — Introduction and Foundational Concepts — Questions 1–15
2. Section II — Core Oncology Concepts and Treatment — Questions 16–45
3. Section III — Applied Clinical Scenarios — Questions 46–75
4. Section IV — Critical Thinking and Advanced Practice — Questions 76–100
5. Section V — Comprehensive Review Questions — Questions 101–125
6. Answer and Rationale Guide
7. High-Yield AOCNP® Review Terms
Instructions
1. Select the single best answer for each multiple-choice question.
, 2. For short-answer questions, provide the most clinically appropriate response.
3. Assume that the patient is an adult unless otherwise stated.
4. When a medication, treatment, or intervention is mentioned, apply current evidence-
based oncology practice and institutional safety requirements.
5. For board preparation, distinguish between a screening, diagnostic, prognostic, and
predictive test.
6. Each question is followed immediately by its correct answer and rationale to facilitate
active review.
The AOCNP® examination is organized around the cancer continuum, cancer
treatment/supportive care, disease-specific oncology, symptom management, and
professional/advanced-practice domains. The distribution below is intentionally broad so that the
practice examination assesses both knowledge and clinical application.
SECTION I — INTRODUCTION AND FOUNDATIONAL CONCEPTS
Questions 1–15
Question 1
Which statement best describes a predictive biomarker?
A. It estimates the patient's overall survival regardless of treatment.
B. It identifies the likelihood that a patient will respond to a particular therapy.
C. It identifies the anatomic extent of disease.
D. It determines the patient's performance status.
Correct Answer: B
Rationale: A predictive biomarker helps determine whether a particular treatment is likely to
benefit a patient. Prognostic biomarkers, by contrast, provide information about disease outcome
independent of a particular therapy.
Question 2
Which factor is most important when interpreting a cancer staging result?
A. The patient's preferred pharmacy
B. Tumor burden and extent of disease
C. The patient's marital status
D. The number of medications prescribed
,Correct Answer: B
Rationale: Cancer staging describes the extent of malignancy and commonly incorporates tumor
characteristics, regional lymph-node involvement, and distant metastases. Stage strongly
influences prognosis and treatment selection.
Question 3
A patient with newly diagnosed cancer asks why the oncology team wants to review family
history. What is the best response?
A. Family history is used only to determine insurance coverage.
B. Family history can identify patterns suggesting hereditary cancer susceptibility.
C. Family history determines the patient's performance status.
D. Family history replaces tumor testing.
Correct Answer: B
Rationale: A detailed three-generation family history can reveal patterns suggestive of inherited
cancer predisposition. Germline assessment and genetic counseling may be appropriate when
hereditary risk is suspected.
Question 4
Which assessment tool is commonly used to describe functional status in oncology patients?
A. Glasgow Coma Scale
B. Eastern Cooperative Oncology Group Performance Status
C. Apgar score
D. Braden Scale
Correct Answer: B
Rationale: ECOG Performance Status evaluates functional impairment and ability to perform
activities of daily living. Performance status is frequently incorporated into oncology treatment
decisions and clinical-trial eligibility.
Question 5
Which statement best distinguishes palliative care from hospice care?
A. Palliative care is appropriate only during the final days of life.
B. Hospice and palliative care are identical services.
, C. Palliative care can be provided concurrently with disease-directed treatment.
D. Palliative care excludes symptom management.
Correct Answer: C
Rationale: Palliative care focuses on symptom relief, quality of life, communication, and
support and can occur alongside cancer-directed therapy. Hospice generally focuses on comfort
when the goals of care have shifted away from curative or life-prolonging treatment.
Question 6
Which intervention best demonstrates shared decision-making?
A. The clinician selects treatment without patient input.
B. The patient makes the decision without receiving medical information.
C. The clinician explains evidence, risks, benefits, alternatives, and incorporates the patient's
goals.
D. The family selects the treatment regardless of the patient's preferences.
Correct Answer: C
Rationale: Shared decision-making integrates clinical evidence with patient values, goals,
preferences, and circumstances. It is particularly important when multiple medically reasonable
options exist.
Question 7
A patient's cancer is described as metastatic. What does this generally indicate?
A. The primary tumor has become benign.
B. Cancer has spread to distant sites.
C. The cancer is necessarily terminal.
D. The patient cannot receive systemic therapy.
Correct Answer: B
Rationale: Metastatic disease means malignant cells have spread from the primary site to distant
tissues or organs. Metastatic cancer is serious but is not synonymous with an immediate terminal
prognosis; treatment options vary substantially by cancer type and biology.
Question 8
FOR ADVANCED ONCOLOGY CERTIFIED NURSE PRACTITIONER
(2026) BOARD EXAM PREP (PDF)
AOCNP® 2026 Board Exam Preparation
Comprehensive Academic Practice Examination
120+ Review Questions, Clinical Scenarios, and Key Concepts
Institution: __________________________________________
Examination Type: Advanced Oncology Certified Nurse Practitioner (AOCNP®)
Practice Examination
Recommended Level: Graduate/Advanced Practice Nursing
Total Questions: 125
Format: Multiple Choice and Short Answer
Purpose: Board-examination preparation and advanced oncology knowledge
assessment
Important educational notice: This is an original practice examination created for
study and educational use.
Table of Contents
1. Section I — Introduction and Foundational Concepts — Questions 1–15
2. Section II — Core Oncology Concepts and Treatment — Questions 16–45
3. Section III — Applied Clinical Scenarios — Questions 46–75
4. Section IV — Critical Thinking and Advanced Practice — Questions 76–100
5. Section V — Comprehensive Review Questions — Questions 101–125
6. Answer and Rationale Guide
7. High-Yield AOCNP® Review Terms
Instructions
1. Select the single best answer for each multiple-choice question.
, 2. For short-answer questions, provide the most clinically appropriate response.
3. Assume that the patient is an adult unless otherwise stated.
4. When a medication, treatment, or intervention is mentioned, apply current evidence-
based oncology practice and institutional safety requirements.
5. For board preparation, distinguish between a screening, diagnostic, prognostic, and
predictive test.
6. Each question is followed immediately by its correct answer and rationale to facilitate
active review.
The AOCNP® examination is organized around the cancer continuum, cancer
treatment/supportive care, disease-specific oncology, symptom management, and
professional/advanced-practice domains. The distribution below is intentionally broad so that the
practice examination assesses both knowledge and clinical application.
SECTION I — INTRODUCTION AND FOUNDATIONAL CONCEPTS
Questions 1–15
Question 1
Which statement best describes a predictive biomarker?
A. It estimates the patient's overall survival regardless of treatment.
B. It identifies the likelihood that a patient will respond to a particular therapy.
C. It identifies the anatomic extent of disease.
D. It determines the patient's performance status.
Correct Answer: B
Rationale: A predictive biomarker helps determine whether a particular treatment is likely to
benefit a patient. Prognostic biomarkers, by contrast, provide information about disease outcome
independent of a particular therapy.
Question 2
Which factor is most important when interpreting a cancer staging result?
A. The patient's preferred pharmacy
B. Tumor burden and extent of disease
C. The patient's marital status
D. The number of medications prescribed
,Correct Answer: B
Rationale: Cancer staging describes the extent of malignancy and commonly incorporates tumor
characteristics, regional lymph-node involvement, and distant metastases. Stage strongly
influences prognosis and treatment selection.
Question 3
A patient with newly diagnosed cancer asks why the oncology team wants to review family
history. What is the best response?
A. Family history is used only to determine insurance coverage.
B. Family history can identify patterns suggesting hereditary cancer susceptibility.
C. Family history determines the patient's performance status.
D. Family history replaces tumor testing.
Correct Answer: B
Rationale: A detailed three-generation family history can reveal patterns suggestive of inherited
cancer predisposition. Germline assessment and genetic counseling may be appropriate when
hereditary risk is suspected.
Question 4
Which assessment tool is commonly used to describe functional status in oncology patients?
A. Glasgow Coma Scale
B. Eastern Cooperative Oncology Group Performance Status
C. Apgar score
D. Braden Scale
Correct Answer: B
Rationale: ECOG Performance Status evaluates functional impairment and ability to perform
activities of daily living. Performance status is frequently incorporated into oncology treatment
decisions and clinical-trial eligibility.
Question 5
Which statement best distinguishes palliative care from hospice care?
A. Palliative care is appropriate only during the final days of life.
B. Hospice and palliative care are identical services.
, C. Palliative care can be provided concurrently with disease-directed treatment.
D. Palliative care excludes symptom management.
Correct Answer: C
Rationale: Palliative care focuses on symptom relief, quality of life, communication, and
support and can occur alongside cancer-directed therapy. Hospice generally focuses on comfort
when the goals of care have shifted away from curative or life-prolonging treatment.
Question 6
Which intervention best demonstrates shared decision-making?
A. The clinician selects treatment without patient input.
B. The patient makes the decision without receiving medical information.
C. The clinician explains evidence, risks, benefits, alternatives, and incorporates the patient's
goals.
D. The family selects the treatment regardless of the patient's preferences.
Correct Answer: C
Rationale: Shared decision-making integrates clinical evidence with patient values, goals,
preferences, and circumstances. It is particularly important when multiple medically reasonable
options exist.
Question 7
A patient's cancer is described as metastatic. What does this generally indicate?
A. The primary tumor has become benign.
B. Cancer has spread to distant sites.
C. The cancer is necessarily terminal.
D. The patient cannot receive systemic therapy.
Correct Answer: B
Rationale: Metastatic disease means malignant cells have spread from the primary site to distant
tissues or organs. Metastatic cancer is serious but is not synonymous with an immediate terminal
prognosis; treatment options vary substantially by cancer type and biology.
Question 8
